Inhibiting AARS1 activity genetically or with β-alanine or reducing lactate production with oxamate or the clinical lactate dehydrogenase (LDHA) inhibitor stiripentol sensitized ESCC cells to cuproptosis [58]. Here, AARS1 is linked to esophageal squamous cell carcinoma.